Sirion Therapeutics U.S. Rights for Eye Treatment to Bausch & Lomb (BOL)
6/3/2010 8:15:01 AM
More...
|
Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes
4/26/2010 8:47:09 AM
More...
|
Alcon, Inc. (ACL) Completes Acquisition of DUREZOL(TM) and ZYCLORIN(TM) from Sirion Therapeutics
3/30/2010 8:50:16 AM
More...
|
Alcon, Inc. (ACL) to Purchase Ophthalmic Pharmaceutical Assets from Sirion Therapeutics
1/19/2010 10:36:37 AM
More...
|
Sirion Therapeutics Announces FDA Approval of Zirgan(TM) 0.15% for Herpetic Keratitis Zirgan
9/16/2009 8:46:48 AM
More...
|
Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology Annual Meeting
4/30/2009 12:15:20 PM
More...
|
Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide
4/15/2009 8:23:29 AM
More...
|
Sirion Therapeutics Supplemental New Drug Application for Durezol(TM) to Treat Uveitis is Accepted for Review by the FDA
3/16/2009 9:59:58 AM
More...
|
Sirion Therapeutics Partners With Advanced Vision Research to Promote Products for Retinal and Meibomian Gland Health
2/17/2009 8:54:44 AM
More...
|
Sirion Therapeutics New Drug Application for Ganciclovir is Accepted for Review by the FDA for the Treatment of Ocular Herpes
1/26/2009 9:57:07 AM
More...
|
|